Profile
CEMI DHR-PB TMO DHR A IDXX
Company Name Chembio Diagnostics, Inc. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation Agilent Technologies, Inc. IDEXX Laboratories, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $16.71M $916.76B $227.24B $196.87B $45.20B $44.88B
Employees 0.19K 79.00K 122.00K 61.00K 17.70K 11.00K
CEO Mr. Richard L. Eberly Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Henrik Ancher-Jensen Mr. Jonathan J. Mazelsky
Ratings
Trading
CEMI DHR-PB TMO DHR A IDXX
Last Close $0.455 $1261.26 $595.3 $265.8 $154.23 $543.45
High 52 $0.46 $1261.26 $599.43 $265.8 $154.31 $576.87
Low 52 $0.46 $1261.26 $431.41 $185.1 $101.17 $391.37
Price vs. 52 Week High -1.09 % 0 % -0.69 % 0 % -0.05 % -5.79 %
Price vs. 52 Week Low -1.09 % 0 % 37.99 % 43.6 % 52.45 % 38.86 %
Total Return
CEMI DHR-PB TMO DHR A IDXX
1 Month Return 0 % 0 % 9.93 % 12.46 % 16.45 % 13.74 %
3 Month Return 0 % 0 % 8.66 % 6.32 % 14.38 % -2.18 %
6 Month Return 0 % 0 % 27.63 % 27.92 % 36.31 % 17.2 %
9 Month Return 0 % 0 % 11.82 % 5.72 % 29.33 % 12.35 %
YTD Return 0 % 0 % 12.15 % 14.9 % 10.93 % -2.09 %
1 Year Return 0 % 0 % 13.71 % 17.39 % 19.43 % 10.44 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
CEMI DHR-PB TMO DHR A IDXX
Dividend Yield Percentage (TTM) - 0.38 % 0.24 % 0.38 % 0.6 % -
Dividend Paid and Capex Coverage Ration (TTM) -24.98 % 3.16 % 4.68 % 2.65 % 3.39 % 7.41 %
Dividend Per Share (TTM) - 1.02 % 1.44 % 1.02 % 0.92 % -
Payout Ratio (TTM) - 17.87 % 8.97 % 27.74 % 21.6 % -
Growth
CEMI DHR-PB TMO DHR A IDXX
Asset Growth -14.53 % 0.16 % 1.62 % 0.16 % 2.35 % 18.68 %
Gross Profit Growth 301.57 % -25.94 % -21.93 % -25.94 % -6.9 % 9.26 %
Revenue Growth 30.91 % -24.09 % -4.58 % -24.09 % -0.22 % 8.72 %
Revenue 3 Year -2.14 % 2.8 % 36.47 % 2.8 % 34.51 % 38.96 %
Revenue 5 Year 1.89 % 14.24 % 83.24 % 14.24 % 51.82 % 72.97 %
Revenue 10 Year -37.97 % 18.09 % 205.6 % 18.09 % 16.86 % 240.27 %
EBIT Growth 15.01 % -40.12 % -12.81 % -40.12 % -16.56 % 22.07 %
Net Income Growth 31.3 % -33.92 % -13.74 % -33.92 % -1.12 % 24.44 %
Net Income 3 Yeari Growth Per Share -18.83 % 25.29 % -3.52 % 25.29 % 81.26 % 49.23 %
Net Income 5 Yeari Growth Per Share -85.03 % 70.95 % 112.51 % 70.95 % 328.44 % 134.38 %
Net Income 10 Yeari Growth Per Share -913.2 % 67.05 % 339.48 % 67.05 % 98.65 % 475.93 %
Operating Income Growth 15.01 % -40.12 % -12.81 % -40.12 % -16.56 % 22.07 %
Operating Cash Flow Growth (CFG) 58.9 % -15.91 % -8.17 % -15.91 % 35.06 % 66.95 %
Operating 3 Year CFG 2.19 % 10.65 % 4.04 % 10.65 % 102.22 % 43.71 %
Operating 5 Year CFG -27.63 % 69.44 % 92.7 % 69.44 % 77.99 % 136.94 %
Operating 10 Year CFG -648.15 % 88.83 % 290.23 % 88.83 % 78.41 % 371.66 %
EPS Growth 31.43 % -34.29 % -12.41 % -34.29 % 0.72 % 25.25 %
EPS Diluted Growth 31.43 % -33.82 % -12.41 % -33.82 % 0.24 % 25.28 %
Book Value Per Share -48.06 % 5.14 % 7.9 % 5.14 % 12.39 % 145.51 %
Share Holder 3 Year Equity Growth Per Share -48.33 % 28.97 % 38.91 % 28.97 % 26.07 % 141.3 %
Share Holder 5 Year Equity Growth Per Share -31.12 % 80.33 % 76.4 % 80.33 % 39.74 % 16418.79 %
Share Holder 10 Year Equity Growth Per Share -57.84 % 125.79 % 158.74 % 125.79 % 28.25 % 266.68 %
Dividend Per Share Growth - 50.21 % 16.73 % 50.21 % 7.8 % -
Dividend 3 Year Growth Per Share - 94.58 % 59.21 % 94.58 % 25.46 % -
Dividend 5 Year Growth Per Share - - - - - -
Dividend 10 Year Growth Per Share - 2163.67 % 125.8 % 2163.67 % 97.03 % -
Debt Growth -3 % -0.72 % 1.24 % -0.72 % -1.23 % -29.7 %
Free Cash Flow Growth 56.8 % -21.53 % 0.23 % -21.53 % 44.37 % 96.09 %
Updated On 31 Dec 2022 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Oct 2023 31 Dec 2023
Profitability
CEMI DHR-PB TMO DHR A IDXX
Gross Profit Margin TTM 25.02 % 58.45 % 41.2 % 58.4 % 50.63 % 60.14 %
Return on Assets TTM -14.68 % 5.33 % 6.21 % 5.28 % 11.29 % 25.84 %
Return on Equity TTM -51.64 % 8.42 % 13.31 % 8.34 % 21.15 % 63.66 %
Return on Capital Employed TTM -39.37 % 7.39 % 8.44 % 5.54 % 14.19 % 46.55 %
Net Income Per EBT TTM 122.1 % 83.98 % 92.49 % 97.45 % 92.79 % 79.58 %
EBT Per Ebit TTM 82.01 % 94.74 % 92.99 % 107.86 % 100.6 % 97.61 %
EBIT Per Revenue TTM -45.07 % 21.3 % 16.51 % 18.6 % 19.66 % 29.95 %
Cash Flow To Debt Ratio TTM -31.46 % 36.11 % 25.07 % 36.11 % 75.39 % 86.18 %
Receivables Turnover TTM 1.09 7.76 4.54 6.66 5.2 6.44
Payables Turnover TTM 4.57 6.49 9.78 5.58 6.81 12.64
Inventory Turnover TTM 1.98 4.12 4.87 3.54 3.22 3.8
Fixed Asset Turnover TTM 148.36 % 463.28 % 455.73 % 397.72 % 458.48 % 449.53 %
Asset Turnover TTM 32.52 % 31.45 % 43.76 % 27 % 61.52 % 111.07 %
Operating Cash Flow Per Share TTM -0.32 9.27 23.37 9.39 6.69 11.09
Free Cash Flow Per Share TTM -0.34 7.39 19.79 7.5 5.63 9.59
Cash Per Share TTM 74.81 % 937.04 % 1899.74 % 949.37 % 596.59 % 478.28 %
Operating Cash Flow Sales Ratio TTM -38.76 % 26.52 % 21.01 % 30.89 % 29.12 % 24.73 %
Free Cash Flow Operating Cash Flow Ratio TTM 104 % 79.76 % 84.68 % 79.89 % 84.09 % 86.5 %
Cash Flow Coverage Ratios TTM -31.46 % 36.11 % 25.07 % 36.11 % 75.39 % 86.18 %
Price To Free Cash Flows Ratio TTM -2.04 35.49 30.06 35.43 27.41 56.33
Price To Operating Cash Flows Ratio TTM -1.4 28.67 25.47 28.3 23.04 49.02
Price Cash Flow Ratio TTM -1.4 28.67 25.47 28.3 23.04 49.02
Income Statement (TTM)
CEMI DHR-PB TMO DHR A IDXX
Revenue $0.05B $23.89B $42.86B $23.89B $6.83B $3.66B
Gross Profit $0.01B $14.03B $15.22B $14.03B $3.47B $2.19B
Gross Profit Ratio 20.19% 58.74% 35.52% 58.74% 50.71% 59.82%
EBITDA $-0.01B $7.76B $10.72B $7.76B $1.71B $1.1B
Net Income $-0.02B $4.76B $6B $4.76B $1.24B $0.85B
EPS Diluted -0.96 6.38 15.45 6.38 4.19 10.06
Balance Sheet (MRQ)
CEMI DHR-PB TMO DHR A IDXX
Long Term Debt $0.01B $17.66B $31.31B $17.66B $2.74B $0.62B
Total Liabilities $0.04B $31B $51.88B $31B $4.92B $1.78B
Total Equity $0.02B $53.49B $46.84B $53.49B $5.85B $1.48B
Total Investments $0B $0.01B $-1.92B $0.01B $0.16B $0.06B
Total Debt $0.03B $19.54B $34.92B $19.54B $2.74B $0.95B
Total Assets $0.06B $84.49B $98.73B $84.49B $10.76B $3.26B
Cash Flow Statement (TTM)
CEMI DHR-PB TMO DHR A IDXX
Net Income $-0.02B $4.22B $6B $4.22B $1.24B $0.85B
Inventory $0B $0.19B $0.6B $0.19B $-0.03B $-0.03B
Dividends Paid $0B $-1.25B $-0.52B $-1.25B $-0.27B $0B
Operating Cash Flow $-0.01B $7.16B $8.41B $7.16B $1.77B $0.91B
Capital Expenditure $-0B $-1.38B $-1.48B $-1.38B $-0.3B $-0.13B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 154.23
ACRS Aclaris Therapeutics, Inc. 1.19
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 2.51
AWH Aspira Women's Health Inc. 2.66
BDSX Biodesix, Inc. 1.575
BIAF bioAffinity Technologies, Inc. 2.26
BIAFW bioAffinity Technologies, Inc. 0.32
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 1.14
BNR Burning Rock Biotech Limited 8.3
CDNA CareDx, Inc 15.5
CHEK Check-Cap Ltd. 2.185
CNTG Centogene N.V. 0.37
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 221.61
CSTL Castle Biosciences, Inc. 24.24
DGX Quest Diagnostics Incorporated 144.34
DHR Danaher Corporation 265.8
DHR-PA Danaher Corporation 1841.01
ETFs With Exposure to CEMI
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 116.35
Unlock